[PDF][PDF] CTA evaluation of basilar septations: an entity better characterized as aberrant basilar fenestrations
JE Small, MB Macey, AK Wakhloo… - American Journal of …, 2021 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: A basilar artery intraluminal septation is an exceedingly
rarely reported, presumed congenital abnormality. In our clinical practice, we have …
rarely reported, presumed congenital abnormality. In our clinical practice, we have …
Spinal epidural venous plexus pathology in Hirayama disease
MB Macey, DT Ho, CM Parres… - Journal of Clinical …, 2019 - journals.lww.com
Hirayama disease is a rare juvenile amyotrophy that is often misdiagnosed as an unrelated,
relentlessly progressive disease. We present the case of an 18-year-old man who presented …
relentlessly progressive disease. We present the case of an 18-year-old man who presented …
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I study
…, MB Khazaeli, CY Lin, DJ Macey… - Cancer Biotherapy …, 2001 - liebertpub.com
A phase I trial was designed to examine the feasibility of combining interferon and Taxol with
intraperitoneal radioimmunotherapy ( 177 Lu-CC49). Patients with recurrent or persistent …
intraperitoneal radioimmunotherapy ( 177 Lu-CC49). Patients with recurrent or persistent …
Normative Measurements of Orbital Walls and Contents
MB Macey, JE Small, DT Ginat - … of Normative Measurements in Head and …, 2021 - Springer
This chapter reviews the normal measurements of the orbital contents and walls on imaging,
with a focus on computed tomography (CT) and magnetic resonance imaging (MRI). The …
with a focus on computed tomography (CT) and magnetic resonance imaging (MRI). The …
Rebreathing methods of determining blood CO2 tension in congenital heart disease
JJ Osborn, MB Macey - Journal of Applied Physiology, 1960 - journals.physiology.org
KINDS OF BREATH-HOLDING or rebreathing techniques have been described for determining
the carbon dioxide tension of the mixed venous blood by analysis of expired air. Collier …
the carbon dioxide tension of the mixed venous blood by analysis of expired air. Collier …
Improved growth rate and disease resistance in farmed Haliotis midae through probiotic treatment
BM Macey, VE Coyne - Aquaculture, 2005 - Elsevier
… Strain SY9 was cultured in marine broth (MB) ((w/v) 3% NaCl, 0.23% MgCl 2 ·6H 2 O, 0.03%
… C and maintained on marine agar (MA) (MB supplemented with 2% bacteriological agar (w/v…
… C and maintained on marine agar (MA) (MB supplemented with 2% bacteriological agar (w/v…
Improved prediction of myelotoxicity using a patient-specific imaging dose estimate for non-marrow-targeting 90Y-antibody therapy
…, J Duan, DJ Macey, MB Khazaeli… - Journal of Nuclear …, 2002 - Soc Nuclear Med
For calculation of radiation dose to the marrow, standard dosimetry for radiopharmaceuticals
that do not bind to the marrow includes dose contributions from radioactivity in blood and …
that do not bind to the marrow includes dose contributions from radioactivity in blood and …
Structural brain alterations in children an average of 5 years after surgery and chemotherapy for brain tumors
Young children with brain tumors are often treated with high-dose chemotherapy after
surgery to avoid brain tissue injury associated with irradiation. The effects of systemic …
surgery to avoid brain tissue injury associated with irradiation. The effects of systemic …
Phase II Study of Interferon-enhanced 131I-Labeled High Affinity CC49 Monoclonal Antibody Therapy in Patients with Metastatic Prostate Cancer
RF Meredith, MB Khazaeli, DJ Macey, WE Grizzle… - Clinical cancer …, 1999 - AACR
Adjuvant Interferon (IFN) was given to increase tumor antigen expression and enhance
localization with 131 I-labeled CC49 radioimmunotherapy in a Phase II trial for hormone resistant …
localization with 131 I-labeled CC49 radioimmunotherapy in a Phase II trial for hormone resistant …
Comparison of biodistribution, dosimetry, and outcome from clinical trials of radionuclide-CC49 antibody therapy
R Meredith, S Shen, D Macey, MB Khazaeli… - Cancer Biotherapy …, 2003 - liebertpub.com
CC49 is a second-generation murine antibody with anti-TAG-72 (tumor-associated antigen)
reactivity. For cancer therapy, it has the advantage of being expressed on adenocarcinomas …
reactivity. For cancer therapy, it has the advantage of being expressed on adenocarcinomas …